Exports In 2023, Spain exported $6.01B in Vaccines, blood, antisera, toxins and cultures, making it the 14th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in Spain. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Spain are: United States ($969M), Belgium ($962M), Japan ($855M), Ireland ($575M), and Germany ($345M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Spain between 2022 and 2023 were Belgium ($893M), Israel ($109M), and Hungary ($57.7M).
Imports In 2023, Spain imported $6B in Vaccines, blood, antisera, toxins and cultures, becoming the 14th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Spain. Spain imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.48B), Switzerland ($1.09B), Germany ($1.07B), Netherlands ($940M), and Belgium ($503M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Spain between 2022 and 2023 were Netherlands ($253M), United States ($110M), and Argentina ($34.4M).